Related Experiment Video

Updated: Apr 4, 2026

Conducting Respiratory Oscillometry in an Outpatient Setting
14:49

Conducting Respiratory Oscillometry in an Outpatient Setting

Published on: April 8, 2022

8.9K

An impulse oscillometry system is less efficient than spirometry in tracking lung function improvements after

Clélia Buchs1, Laurianne Coutier2, Stéphanie Vrielynck1,3

  • 1Centre de ressources et de compétences de la mucoviscidose, Lyon, France.

Pediatric Pulmonology
|September 5, 2015
PubMed

Insights

Impulse oscillometry (IOS) shows potential for tracking lung function changes in pediatric cystic fibrosis patients after intravenous antibiotic therapy (IVAT). However, IOS alone may underestimate treatment effectiveness compared to spirometry (FEV1).

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Physiology

Background:

  • Cystic fibrosis (CF) exacerbations require effective treatment.
  • Intravenous antibiotic therapy (IVAT) is standard for pulmonary exacerbations.
  • Assessing treatment response in pediatric CF is crucial.

Purpose of the Study:

  • To prospectively evaluate the responsiveness of impulse oscillometry (IOS) in pediatric CF patients post-IVAT.
  • To compare IOS-derived measures with spirometry (FEV1) for assessing IVAT efficacy.

Main Methods:

  • Prospective observational study of 34 pediatric CF patients (mean age 11.9 years).
  • Spirometry (FEV1) and IOS (resistance R5, reactance X5) measured at the start and end of IVAT.
  • Statistical analysis of changes (Δ) in FEV1, R5, and X5, and their correlation.

Main Results:

  • Significant improvements observed in FEV1 (ΔFEV1: 20.2%), R5 (ΔR5: -13.4%), and X5 (ΔX5: -21.9%) post-IVAT (P<0.05).
  • Weak but significant correlation between ΔFEV1 and ΔX5 (r=-0.473, P=0.01).
  • IOS (ΔX5) alone identified significant improvement in 44% of patients, versus 79% with FEV1.

Conclusions:

  • IOS can detect changes in lung function following IVAT in pediatric CF patients.
  • IOS alone may be insufficient to fully evaluate IVAT efficacy compared to spirometry.
  • Further research needed to optimize IOS use in CF exacerbation management.

Keywords:
cystic fibrosisexacerbationimpulse oscillometryresponsivenessspirometry

More Related Videos

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults06:11

Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults

Published on: February 9, 2022

6.6K
Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit05:56

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Published on: September 6, 2024

7.3K

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
1.0K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
622
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Respiratory Volumes01:15

Respiratory Volumes

Respiratory volumes are crucial metrics, meticulously measured to quantify the air exchanged in and out of the lungs during various phases of the breathing cycle. These precise measurements are vital for assessing lung function, diagnosing respiratory conditions, and monitoring overall respiratory health. Each parameter provides specific insights into the mechanics of breathing and the functional capacity of the lungs.
Tidal Volume (TV) Tidal volume (TV) is the air inhaled or exhaled in a...
3.5K